PetMedsAnnounces Second Quarter Fiscal 2025 Financial Results
Slightly above 67% of PetMed Express' investor base is looking to short. The analysis of current outlook of investing in PetMed Express suggests that many traders are alarmed regarding PetMed Express' prospects. PetMed Express' investing sentiment can be driven by a variety of factors including economic data, PetMed Express' earnings reports, geopolitical events, and overall market trends.
PetMed |
DELRAY BEACH, Fla., Nov. 06, 2024 -- PetMed Express, Inc. dba PetMeds and parent company of PetCareRx today announced its financial results for its second quarter ended September 30, 2024. Second Quarter Fiscal 2025 Financial Highlights Net sales of 59.6 million.Gross margin of 29.1, an increase of 0.8 percent compared to the prior year period.Net income of 2.3 million, or 0.11 per diluted share, compared to net income of 0.7 million, or 0.03 per diluted share, in
Read at finance.yahoo.com
 |
PetMed Express Fundamental Analysis
We analyze PetMed Express' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of PetMed Express using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of PetMed Express based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
PetMed Express is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
PetMed Express Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with PetMed Express stock to make a market-neutral strategy. Peer analysis of PetMed Express could also be used in its relative valuation, which is a method of valuing PetMed Express by comparing valuation metrics with similar companies.
Peers
PetMed Express Related Equities
| SSY | SunLink Health | 14.67 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Tools for PetMed Stock
When running PetMed Express' price analysis, check to measure PetMed Express' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy PetMed Express is operating at the current time. Most of PetMed Express' value examination focuses on studying past and present price action to predict the probability of PetMed Express' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move PetMed Express' price. Additionally, you may evaluate how the addition of PetMed Express to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal |